Outcomes of a Contemporary Sample of Patients With Atrial Fibrillation Taking Digoxin: Results From the AFBAR Study

Revista Espanola de Cardiologia - Tập 67 - Trang 890-897 - 2014
Moisés Rodríguez-Mañero1, Fernando Otero-Raviña2, Javier García-Seara1, Lucrecia Zugaza-Gurruchaga3, José M. Rodríguez-García4, Rubén Blanco-Rodríguez5, Victorino Turrado Turrado6, José M. Fernández-Villaverde7, Rafael C. Vidal-Pérez1, José R. González-Juanatey1
1Servizo de Cardioloxía, Complexo Hospitalario Universitario de Santiago de Compostela (CHUS), SERGAS, Santiago de Compostela, A Coruña, Spain
2Dirección de Asistencia Sanitaria, SERGAS, Santiago de Compostela, A Coruña, Spain
3Centro de Saúde de Negreira, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Negreira, A Coruña, Spain
4Centro de Saúde de A Pobra do Caramiñal, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, A Pobra do Caramiñal, A Coruña, Spain
5Centro de Saúde de Lousame, Xerencia de Xestión Integrada Santiago de Compostela, SERGAS, Lousame, A Coruña, Spain
6Centro de Saúde Concepción Arenal, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Santiago de Compostela, A Coruña, Spain
7Centro de Saúde de Ribeira, Xerencia de Xestión Integrada de Santiago de Compostela, SERGAS, Ribeira, A Coruña, Spain

Tài liệu tham khảo

Gheorghiade, 2006, Contemporary use of digoxin in the management of cardiovascular disorders, Circulation, 113, 2556, 10.1161/CIRCULATIONAHA.105.560110

Eichhorn, 2002, Digoxin-new perspective on an old drug, N Engl J Med, 347, 1394, 10.1056/NEJMp020118

Friberg, 2010, Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF), Heart, 96, 275, 10.1136/hrt.2009.175786

García-Castelo, 2011, Prognostic impact of atrial fibrillation progression in a community study: AFBAR Study (Atrial Fibrillation in the Barbanza Area Study), Int J Cardiol, 153, 68, 10.1016/j.ijcard.2010.08.042

Wyse, 2002, A comparison of rate control and rhythm control in patients with atrial fibrillation, N Engl J Med, 347, 1825, 10.1056/NEJMoa021328

Murphy, 2013, When ‘digoxin use’ is not the same as ‘digoxin use’: lessons from the AFFIRM trial, Eur Heart J, 34, 1465, 10.1093/eurheartj/eht087

Van Gelder, 2010, Lenient versus strict rate control in patients with atrial fibrillation, N Engl J Med, 362, 1363, 10.1056/NEJMoa1001337

Uretsky, 1993, Randomized study assessing the effect of digoxin withdrawal inpatients with mild to moderate chronic congestive heart failure: results of the PROVED trial, J Am Coll Cardiol, 22, 955, 10.1016/0735-1097(93)90403-N

Packer, 1993, Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study, N Engl J Med, 329, 1, 10.1056/NEJM199307013290101

1988, Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure, JAMA, 259, 539, 10.1001/jama.1988.03720040031022

Di Bianco, 1989, A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure, N Engl J Med, 320, 677, 10.1056/NEJM198903163201101

1988, Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure, Lancet, 1, 489

Guyatt, 1988, A controlled trial of digoxin in congestive heart failure, Am J Cardiol, 61, 371, 10.1016/0002-9149(88)90947-2

1997, The effect of digoxin on mortality and morbidity in patients with heart failure, N Engl J Med, 336, 525, 10.1056/NEJM199702203360801

Rathmore, 2002, Sex-based differences in the effect of digoxin for the treatment of heart failure, N Engl J Med, 347, 1403, 10.1056/NEJMoa021266

Flory, 2012, Observational cohort study of the safety of digoxin use in women with heart failure, BMJ Open, 2, e000888, 10.1136/bmjopen-2012-000888

Domanski, 2005, The effect of gender on outcome in digitalis-treated heart failure patients, J Card Fail, 11, 83, 10.1016/j.cardfail.2004.07.002